Skip to content

A Single-Center Randomized Controlled Study on the Application of Thermosensitive Endoscopic Ultrasound Coupling Agent in Endoscopic Ultrasonography for Duodenal Lesions

A Single-Center Randomized Controlled Study on the Application of Thermosensitive Endoscopic Ultrasound Coupling Agent in Endoscopic Ultrasonography for Duodenal Lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122500
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duodenal protruding lesion or duodenal ampullary lesion

Interventions

Experimental group:Use temperature-sensitive endoscopic ultrasound coupling agent

Sponsors

The Second Affiliated Hospital of Army Medical University of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years, gender unrestricted; 2.Duodenal exophytic lesions or ampullary lesions of the duodenum require endoscopic ultrasound (EUS) examination; 3.Voluntarily accept and comply with this experimental protocol, attend scheduled re-examinations and follow-ups on time, and have signed the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Individuals with severe cardiac disease (NYHA class >= IV), pulmonary disease, or implanted pacemakers who are unable to tolerate upper gastrointestinal endoscopy; 2.Individuals with coagulation dysfunction (prothrombin time >= 18 seconds), those with bleeding disorders, and patients taking oral anticoagulants; 3.Patients with corrosive esophagitis, acute severe pharyngeal diseases, duodenal stenosis, or other conditions where endoscopy cannot be inserted into the duodenum; 4.Individuals unable to tolerate painless endoscopic ultrasonography; 5.Female individuals who were pregnant or lactating at the time of screening; 6.Individuals who participated in other clinical trials within three months prior to the trial; 7.Other conditions deemed unsuitable for inclusion by researchers;

Design outcomes

Primary

MeasureTime frame
EUS Image Quality Scoring;Incidence and occurrence frequency of adverse reactions during EUS examination;

Secondary

MeasureTime frame
The concordance rate between EUS diagnostic results and postoperative pathological diagnosis;Abdominal pain, diarrhea, abdominal distension, vomiting, cough, fever, and constipation within 24 hours after EUS;Coupling agent/normal saline volume;EUS procedure duration;The frequency of duodenal peristalsis;

Countries

China

Contacts

Public ContactChaoqiang Fan

The Second Affiliated Hospital of Army Medical University of the Chinese People's Liberation Army

fcqxhkwjs@126.com+86 23 6877 4204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026